An imaging approach developed at UZH enables the study of breast cancer tissue in greater detail. It uses 35 biomarkers to identify the different cell types in breast tumors and its surrounding area compared to the current standard of testing single markers. This increases the precision of tumor analysis and classification - and improves personalized diagnostics for breast cancer patients.

After identifying 107 genes that increase a person’s risk of developing the eye disease glaucoma, researchers have now developed a genetic test to detect those at risk of going blind from it.

A new type of scan has been developed that involves magnetizing molecules – it allows physicians to observe in real-time which regions of a breast tumor are active.

Today an emergency committee convened in Geneva to discuss whether or not the current outbreak of a novel coronavirus in China should be declared a “public health emergency of international concern.”

If you want to build a foundational understanding of genomics in both health and disease, it's important to be able to distinguish between the different type of genetic mutations that can occur. Here, we take a look at some of the mutations that can be encountered and the impact they have on the genome.

In epidemiology, prevalence and incidence are among the most fundamental measures when it comes to monitoring disease. But do you know what they mean or how and why they are important? This article takes a look at disease prevalence and incidence, what this information tells us and how it can be used.

Liquid biopsies are tests conducted on blood samples that examine biomarkers shed by tumors, such as cancer cells or pieces of tumor DNA. The data from liquid biopsies can be used in place of or alongside that of traditional surgical biopsies. In this article, we review the theory behind liquid biopsies and their applications in cancer medicine.

With so many potential routes for food contaminants, both natural and otherwise, having the tools to detect them, determine the source of the problem and prevent them from reaching the consumer is therefore vitally important. In this article, we explore how 2DLC is being implemented to improve food safety and contaminant traceability.

At first glance this question might seem like a no-brainer. Surely if you make an infectious disease notifiable then you are better able to contain infection and prevent it spreading, right? Unfortunately, whilst the principle seems simple, the reality is far less so. Here we take a look at the different facets and implications of making an infectious disease notifiable.